Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

SBPH Insider Trading

SBPH | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at SBPH provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2020-11-23 19:14 2020-11-20 Winslow Garrett Officer - General Counsel and Secretary OPT+S $4.76 175 $833 18,575 0.0%
2020-11-23 19:12 2020-11-20 Firmani Lori Officer - VP of Finance and Treasurer OPT+S $4.76 175 $833 17,867 0.0%
2020-11-23 19:10 2020-11-20 Iyer Radhakrishnan P. Officer - Chief Scientific Officer OPT+S $4.76 175 $833 125,137 0.0%
2020-11-23 19:14 2020-11-20 Driscoll Martin J Director, Officer - President and CEO OPT+S $4.76 175 $833 47,425 0.0%
2020-01-03 01:16 2019-12-30 Eichler Kurt M Director SELL $1.26 40,000 $50,540 549,273 -6.8%
2019-11-15 00:08 2019-11-14 Freve Jonathan Officer - CFO & Treasurer BUY $3.04 5,000 $15,200 17,482 +40.1%
2019-11-14 16:46 2019-11-13 Driscoll Martin J Director, Officer - President and CEO BUY $2.83 5,000 $14,150 90,400 +5.9%
2019-06-28 22:25 2019-06-28 Smith Scott Andrew Director BUY $4.09 12,000 $49,080 13,883 +637.3%
2019-05-29 17:16 2019-05-29 Freve Jonathan Officer - CFO & Treasurer BUY $5.40 5,000 $27,000 12,482 +66.8%
2019-05-29 18:22 2019-05-29 Driscoll Martin J Director, Officer - President and CEO BUY $6.03 10,000 $60,300 85,400 +13.3%
2019-05-22 16:10 2019-05-21 Driscoll Martin J Director, Officer - President and CEO BUY $6.63 5,000 $33,150 75,400 +7.1%
2019-04-30 22:17 2019-04-30 Driscoll Martin J Director, Officer - President and CEO BUY $7.34 10,000 $73,350 70,400 +16.6%
2018-08-13 23:04 2018-08-13 Driscoll Martin J Director, Officer - President and CEO BUY $12.02 4,000 $48,080 60,400 +7.1%
2018-03-02 00:01 2018-02-28 Driscoll Martin J Director, Officer - President and CEO BUY $12.83 1,000 $12,830 56,400 +1.8%
2017-09-14 23:03 2017-09-14 Driscoll Martin J Director, Officer - President and CEO BUY $14.84 1,000 $14,840 55,400 +1.8%
2017-08-07 23:02 2017-08-04 Arkowitz David Director BUY $12.24 2,500 $30,602 19,386 +14.8%
2017-08-03 23:02 2017-08-03 Driscoll Martin J Director, Officer - President and CEO BUY $12.36 2,000 $24,710 54,400 +3.8%
2017-06-28 00:04 2017-06-27 Eichler Kurt M Director BUY $13.00 76,923 $999,999 582,533 +15.2%
2017-03-08 00:57 2017-03-07 Driscoll Martin J Director, Officer - President and CEO BUY $9.44 2,000 $18,880 52,400 +4.0%
2017-02-28 00:14 2017-02-23 Eichler Kurt M Director BUY $8.76 1,200 $10,516 1,200 +100.0%
2016-12-16 18:28 2016-12-15 Driscoll Martin J Director, Officer - President and CEO BUY $8.50 2,000 $17,000 50,400 +4.1%
2016-12-02 00:07 2016-11-30 Driscoll Martin J Director, Officer - President and CEO BUY $7.98 2,000 $15,960 48,400 +4.3%
2016-11-11 01:04 2016-11-09 Eichler Kurt M Director BUY $8.69 7,000 $60,830 437,990 +1.6%
2016-11-11 01:01 2016-11-09 Driscoll Martin J Director, Officer - President and CEO BUY $8.84 2,000 $17,680 24,500 +8.9%
2016-09-20 23:13 2016-09-16 Eichler Kurt M Director BUY $12.50 1,996 $24,950 430,990 +0.5%
2016-09-15 23:03 2016-09-14 Eichler Kurt M Director BUY $12.50 514 $6,425 428,994 +0.1%
2016-09-14 23:06 2016-09-13 Eichler Kurt M Director BUY $12.50 490 $6,125 428,480 +0.1%
2016-09-12 23:04 2016-09-09 Afdhal Nezam H. Officer - Chief Medical Officer BUY $12.50 2,400 $30,000 40,150 +6.4%
2016-09-02 23:11 2016-09-02 Driscoll Martin J Director, Officer - President and CEO BUY $11.75 1,000 $11,750 22,500 +4.7%
2016-08-31 23:07 2016-08-30 Driscoll Martin J Director, Officer - President and CEO BUY $12.41 1,000 $12,410 21,500 +4.9%
2016-08-25 03:49 2016-08-24 Afdhal Nezam H. Officer - Chief Medical Officer BUY $11.92 2,000 $23,844 37,750 +5.6%
2016-08-25 03:41 2016-08-23 Eichler Kurt M Director BUY $10.73 3,000 $32,190 427,990 +0.7%
2016-08-24 03:43 2016-08-23 Freve Jonathan Officer - CFO, Treasurer & Secretary BUY $10.74 1,000 $10,740 2,000 +100.0%
2016-08-23 00:46 2016-08-19 Driscoll Martin J Director, Officer - President and CEO BUY $11.43 2,000 $22,860 20,500 +10.8%
2016-08-17 00:11 2016-08-15 Afdhal Nezam H. Officer - Chief Medical Officer BUY $11.43 1,900 $21,723 35,750 +5.6%
2016-08-17 01:13 2016-08-10 Afdhal Nezam H. Officer - Chief Medical Officer BUY $11.01 2,600 $28,618 33,850 +8.3%
2016-08-17 00:34 2016-08-15 Driscoll Martin J Director, Officer - President and CEO BUY $11.29 2,000 $22,570 18,500 +12.1%
2016-08-16 02:58 2016-08-12 Afdhal Nezam H. Officer - Chief Medical Officer BUY $11.33 2,600 $29,450 33,850 +8.3%
2016-08-09 20:29 2016-08-09 Driscoll Martin J Director, Officer - President and CEO BUY $11.03 2,000 $22,050 16,500 +13.8%
2016-08-06 00:54 2016-08-04 Freve Jonathan Officer - CFO, Treasurer & Secretary BUY $9.75 1,000 $9,750 1,000 +100.0%
2016-08-06 00:55 2016-08-04 Eichler Kurt M Director BUY $9.79 1,000 $9,790 424,990 +0.2%
2016-08-06 00:53 2016-08-04 Driscoll Martin J Director, Officer - President and CEO BUY $9.96 2,000 $19,920 14,500 +16.0%
2016-05-13 01:41 2016-05-11 Eichler Kurt M Director BUY $12.00 41,666 $499,992 423,990 +10.9%
2016-05-13 01:38 2016-05-11 Driscoll Martin J Director, Officer - President and CEO BUY $12.00 12,500 $150,000 12,500 +100.0%
SHOW ENTRIES

How to Interpret $SBPH Trades

Not every insider transaction in SBPH is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $SBPH shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for SBPH

Insider activity data for SBPH is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $SBPH, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.